TG Therapeutics Q4 2022 Earnings Preview

Feb. 27, 2023 5:55 PM ETTG Therapeutics, Inc. (TGTX)By: Anuron Mitra, SA News Editor

TG Therapeutics (NASDAQ:TGTX) is scheduled to announce Q4 earnings results on Tuesday, February 28th, before market open.
The consensus EPS Estimate is -$0.26 (vs. -$0.70 last year) and the consensus Revenue Estimate is $1.6M (-31.0% Y/Y).
Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward. Revenue estimates have seen 1 upward revision and 0 downward.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.